French stocks experienced an upward trajectory on Tuesday, marking a continuation of gains for the second consecutive day, following U.S. President Donald Trump’s declaration of a temporary halt in military action against Iran, which has fostered optimism regarding a possible agreement between the two conflicting nations.
Trump stated there was a ‘very good chance’ that the United States could secure an agreement with Iran to prevent Tehran from acquiring a nuclear weapon; however, he also indicated that a significant offensive would occur if an acceptable agreement is not reached promptly. The French benchmark CAC 40, which advanced to 8,053.78 earlier, was up 63.95 points or 0.8% at 8,051.44 shortly after noon.
- Capgemini, Dassault Systemes, and Publicis Groupe experienced increases of 4.8%, 4.3%, and 4.1%, respectively.
- Thales experienced an increase of 3.4%, while Eurofins Scientific saw a rise of 2.1%.
- Orange experienced an increase of 1.8%, whereas Airbus, EssilorLuxottica, Danone, Hermes International, Euronext, Bureau Veritas, Safran, and ArcelorMittal saw gains ranging from 1% to 1.5%.
- Sanofi experienced an increase of approximately 0.8%. The drumaker reported that a trial indicated its rare disease therapy was more effective in increasing a crucial lung protein in patients suffering from a genetic variant of lung disease.
- Renault experienced a decline of approximately 1.4%, whereas STMicroelectronics and Michelin recorded decreases of 0.9% and 0.7%, respectively.